Jacob G. Scott, MD, DPhil, discusses the incorporation of genomic-adjusted radiation dose–based radiotherapy dosing in oncology.
Jacob G. Scott, MD, DPhil
Advertisement
Articles by Jacob G. Scott, MD, DPhil
Jacob G. Scott, MD, DPhil, discusses the rationale to evaluate genomic-adjusted radiation dose–based radiotherapy dosing in oncology.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on OncLive
1
Head and Neck Oncologists Highlight Practice-Informing Research From ASCO 2026
2
In Vivo CAR T-Cell Therapy Drives Responses and MRD Negativity in R/R Myeloma
3
FDA Grants Priority Review to Adjuvant Atezolizumab Plus Chemotherapy for Stage III dMMR Colon Cancer
4
Dr Galsky on the Current Roles of Biomarkers in Bladder Cancer
5